17:16 | Merck Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-.. |  |
15:43 | BioNTech SE : El día después |  |
00:51 | Amgen-Sanofi patent case divides makers of antibody drugs |  |
27.03. | Apple CEO Tim Cook Reportedly Met Chinese Commerce Minister to Discuss Industrial Stabi.. |  |
27.03. | Novartis: succès avant terme d'une étude sur Kisqali contre le cancer du sein |  |
27.03. | BioNTech Expects Lower 2023 COVID-19 Vaccine Revenue as Fourth-Quarter Results Drop |  |
27.03. | Merck KGaA Axes Alliance with Pfizer on Skin Cancer Medication Bavencio |  |
27.03. | BioNTech meldt teruglopende vraag naar coronavaccins |  |
27.03. | Cash-rich BioNTech plans to spend about $1 bln more on research this year |  |
27.03. | Novartis grimpe après des résultats prometteurs d'un traitement contre le cancer du sei.. |  |
27.03. | Ministro commercio cinese incontra Ceo Apple Tim Cook |  |
27.03. | El ministro de Comercio chino se reúne con el CEO de Apple, Tim Cook |  |
27.03. | Chinese commerce minister in talks with Apple boss Tim Cook |  |
27.03. | Novartis buoyed by trial success in early-stage breast cancer |  |
27.03. | Pfizer Signs Agreement With China On Improving Health Coverage In The Country - CNBC |  |
27.03. | Pfizer signs agreement with china on improving health coverage i… |  |
25.03. | Apple CEO praises China's innovation, long history of cooperation on Beijing visit |  |
24.03. | Apple: Tim Cook a Pechino malgrado le tensioni tra Usa e Cina |  |
24.03. | Deutsche Bank Adds to Banking-Sector Woes, Pressuring US Equity Futures |  |
24.03. | European Midday Briefing: Bank Worries Continue -2- |  |
24.03. | GSK refutes California state court ruling on Zantac's cancer links |  |
24.03. | North American Morning Briefing: Stock Futures Lower as .. |  |
23.03. | Analysts Model Over 74% Upside For Mainz Biomed Stock Ahead Of Key 1/H 2023 Updates (.. |  |
22.03. | Senators press Moderna CEO on COVID-19 vaccine price hike |  |
22.03. | US FDA grants accelerated approval for Incyte's skin cancer therapy |  |
22.03. | US declines to force lower price on cancer drug Xtandi |  |
22.03. | China autoriza la primera vacuna con ARNm, de una farmacéutica local |  |
22.03. | China approves its first mRNA vaccine, from domestic drugmaker CSPC |  |
22.03. | US declines to force lower price on cancer drug Xtandi |  |
21.03. | U.S. FDA to soon decide on second round of Omicron-tailored boosters - WSJ |  |
21.03. | Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analy.. |  |
21.03. | Moderna: le prix du vaccin anti Covid devrait être de 130 dollars par dose |  |
21.03. | Mainz Biomed ($MYNZ) Inks Accretive Partnership To Expand Marketing Reach Of ColoAlert.. |  |
20.03. | Moderna expects to price its COVID vaccine at about $130 in the US |  |
20.03. | Astellas, Pfizer Log Positive Topline Results from Prostrate Cancer Drug Trial |  |
17.03. | The Week in Numbers: banking on a bailout |  |
17.03. | The Week in Numbers: banking on a bailout |  |
17.03. | FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's .. |  |
17.03. | Humanwell Healthcare Gets Greenlight to Trial Anticonvulsant Drug to Treat Epilepsy |  |
17.03. | Pfizer : données positives pour le Xtandi |  |
17.03. | Pfizer : Vote positif de la FDA pour le PAXVOLID |  |
17.03. | Pfizer, Astellas Pharma Say Prostate Cancer Phase 3 Trial Meets Primary Endpoint |  |
17.03. | SpaceX, Netflix, Boeing to join "biggest-ever" US business mission to Vietnam |  |
17.03. | Pfizer's COVID-19 Drug Secures US FDA Panel Backing for Full Approval |  |
17.03. | Pfizer Says Phase 3 Study Shows Xtandi Plus Leuprolide Improves Metastasis-Free Surviva.. |  |
17.03. | Pfizer- phase 3 study shows xtandi® (enzalutamide) plus leuproli… |  |
17.03. | Pfizer Inc. and Astellas Pharma Inc. Announce Positive Topline Results from Phase 3 EMB.. |  |
16.03. | Advisory panel recommends full FDA approval for COVID-19 medication Paxlovid |  |
16.03. | 19 pill Paxlovid moves closer to full FDA approval |  |
16.03. | 19 pill Paxlovid moves closer to full FDA approval |  |
16.03. | Asesores de la FDA respaldan plena aprobación del tratamiento para el COVID de Pfizer |  |
16.03. | Pfizer's PAXLOVID COVID-19 Treatment Gets Approval From US FDA's Advisory Panel |  |
16.03. | Pfizer's PAXLOVID Wins FDA Advisory Panel Approval |  |
16.03. | FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizer's .. |  |
16.03. | Pfizer's Paxlovid Reportedly Gets FDA Panel Backing for Full Approval |  |
16.03. | U.S. FDA advisers vote in favor of full approval for Pfizer's COVID pill Paxlovid |  |
16.03. | Pfizer to Replace Migraine-Drug Packaging Over Child-Safety Issues -- Update |  |
16.03. | Pfizer Recalls Migraine Drug Due to Packaging Flaw |  |
16.03. | Pfizer : rappel d'un anti-migraineux aux USA |  |
16.03. | Pfizer Recalls Nurtec ODT Migraine Drugs Over Lack of Child-Proof Packaging |  |
16.03. | FDA says Pfizer COVID pill EUA for adolescents to stay even after nod for adults |  |
16.03. | Pfizer Inc Receives Shareholder Proposal from John Chevedden |  |
16.03. | Pfizer Inc Receives Shareholder Proposal from Kenneth Steiner |  |
16.03. | Pfizer Inc Receives Shareholder Proposal from Oxfam America Inc |  |
16.03. | Pfizer Inc Receives Shareholder Proposal from Trinity Health |  |
16.03. | Pfizer Inc Receives Shareholder Proposal from Tara Health Foundation |  |
16.03. | Shares Of Inhibikase Therapeutics Stock Decouples From NASDAQ Weakness; Jump 8% Includi.. |  |
16.03. | Pfizer : 2022 ESG Report |  |
16.03. | Laos, Malawi, Rwanda and Zambia Have Received Oral Antiviral Treatments for High-Risk P.. |  |
16.03. | Fitch Revises Pfizer's Outlook to Stable; Affirms IDR at 'A' |  |
16.03. | Pfizer acquires Seagen for 43 billion USD |  |
15.03. | U.S. issues initial Medicare drug price negotiation guidance |  |
15.03. | FDA panel to consider full approval of Pfizer's COVID-19 drug Paxlovid |  |
15.03. | Five Pfizer Drugs to Cost Less in April After Implementation of Medicare Inflation Reba.. |  |
15.03. | Five Pfizer Drugs to Cost Less in April After Implementation of Medicare Inflation Reba.. |  |
15.03. | Factbox-US government to impose inflation penalties on 27 drugs |  |
15.03. | Royalty Pharma Raises 2023 Adjusted Cash Receipt Guidance After Migraine Treatment Appr.. |  |
15.03. | BioNTech, Pfizer Receive Emergency Use Authorization for Bivalent COVID-19 Vaccine in C.. |  |
15.03. | In The Queue : AcurX Pharmaceuticals Earnings...Here's What Investors Need To Know Before .. |  |
15.03. | Pfizer, BioNTech Obtain Emergency Use Authorization for Bivalent COVID-19 Vaccine in Ki.. |  |
15.03. | Pfizer Inc. and BioNTech SE Receives U.S. Emergency Use Authorization of Omicron BA.4 B.. |  |
15.03. | How GSK plans to replenish its depleted medicine cabinet |  |
15.03. | Pfizer : le rappel covid chez les moins de 5 ans autorisé |  |
15.03. | Gimv neemt deel aan financieringsronde Mediar Therapeutics |  |
15.03. | Pfizer-BioNTech's Omicron-specific COVID-19 Jab Wins US FDA Nod as Booster for Children |  |
15.03. | U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids |  |
14.03. | Pfizer agrees to revise EU COVID vaccine contract -FT |  |
14.03. | Pfizer Reportedly Offers to Change COVID-19 Vaccine Agreement With European Union |  |
14.03. | Pfizer agrees to revise EU COVID vaccine contract - FT |  |
14.03. | Santé & Pharma : consolidation en bonne forme |  |
14.03. | Astellas Announces Phase 3 China ARCHES Study of XTANDI Meets Primary Endpoint |  |
14.03. | Trial data supports Pfizer's COVID drug for high-risk adults -FDA staff |  |
14.03. | Pfizer to acquire Seagen for $43 billion |  |
14.03. | USA-Les valeurs à suivre à Wall Street (actualisé) |  |
14.03. | Inhibikase Therapeutics Stock Turns Bullish After FDA Lifts Full Clinical Hold For Lead.. |  |
14.03. | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Antibiotic Drug |  |
13.03. | Sliding bank stocks drag Wall St. in choppy trade |  |
13.03. | Sliding bank shares drag Wall Street down in choppy trade |  |
13.03. | Point marchés-Wall Street termine en ordre dispersé, les banques toujours en déroute |  |
13.03. | Les Bourses européennes décrochent, Wall Street surmonte la peur |  |